{"id":"https://openalex.org/W2150128170","doi":"https://doi.org/10.1017/s1461145710000180","title":"D3 receptor target engagement in humans with ABT-925 using [11C](+)-PHNO PET","display_name":"D3 receptor target engagement in humans with ABT-925 using [11C](+)-PHNO PET","publication_year":2010,"publication_date":"2010-03-03","ids":{"openalex":"https://openalex.org/W2150128170","doi":"https://doi.org/10.1017/s1461145710000180","mag":"2150128170","pmid":"https://pubmed.ncbi.nlm.nih.gov/20196920"},"language":"en","primary_location":{"id":"doi:10.1017/s1461145710000180","doi":"https://doi.org/10.1017/s1461145710000180","is_oa":true,"landing_page_url":"https://doi.org/10.1017/s1461145710000180","pdf_url":"https://academic.oup.com/ijnp/article-pdf/13/3/291/1865168/13-3-291.pdf","source":{"id":"https://openalex.org/S199972112","display_name":"The International Journal of Neuropsychopharmacology","issn_l":"1461-1457","issn":["1461-1457","1469-5111"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311647","host_organization_name":"University of Oxford","host_organization_lineage":["https://openalex.org/P4310311647"],"host_organization_lineage_names":["University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The International Journal of Neuropsychopharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://academic.oup.com/ijnp/article-pdf/13/3/291/1865168/13-3-291.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Mark Day","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088555","display_name":"Abbott (United States)","ror":"https://ror.org/0052svj16","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088555"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Mark Day","raw_affiliation_strings":["Global Pharmaceutical Research and Development, Translational Neuroimaging, Abbott, Abbott Park, IL60064, USA. mark.day@abbott.com","Global Pharmaceutical Research and Development, Translational Neuroimaging, Abbott, Abbott Park, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Pharmaceutical Research and Development, Translational Neuroimaging, Abbott, Abbott Park, IL60064, USA. mark.day@abbott.com","institution_ids":["https://openalex.org/I4210088555"]},{"raw_affiliation_string":"Global Pharmaceutical Research and Development, Translational Neuroimaging, Abbott, Abbott Park, IL, USA","institution_ids":["https://openalex.org/I4210088555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030348867","display_name":"Earle Bain","orcid":"https://orcid.org/0000-0001-5673-4036","observed_orcids":["https://orcid.org/0000-0001-5673-4036"]},"institutions":[{"id":"https://openalex.org/I4210088555","display_name":"Abbott (United States)","ror":"https://ror.org/0052svj16","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Earle Bain","raw_affiliation_strings":["Global Pharmaceutical Research and Development, Neuroscience, Abbott, Abbott Park, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Pharmaceutical Research and Development, Neuroscience, Abbott, Abbott Park, IL, USA","institution_ids":["https://openalex.org/I4210088555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004332028","display_name":"Gerard J. Marek","orcid":"https://orcid.org/0000-0001-8103-4306","observed_orcids":["https://orcid.org/0000-0001-8103-4306"]},"institutions":[{"id":"https://openalex.org/I4210088555","display_name":"Abbott (United States)","ror":"https://ror.org/0052svj16","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gerard Marek","raw_affiliation_strings":["Global Pharmaceutical Research and Development, Neuroscience, Abbott, Abbott Park, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Pharmaceutical Research and Development, Neuroscience, Abbott, Abbott Park, IL, USA","institution_ids":["https://openalex.org/I4210088555"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Mario Saltarelli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088555","display_name":"Abbott (United States)","ror":"https://ror.org/0052svj16","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mario Saltarelli","raw_affiliation_strings":["Global Pharmaceutical Research and Development, Neuroscience, Abbott, Abbott Park, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Pharmaceutical Research and Development, Neuroscience, Abbott, Abbott Park, IL, USA","institution_ids":["https://openalex.org/I4210088555"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103067241","display_name":"Gerard B. Fox","orcid":"https://orcid.org/0000-0002-1253-1752","observed_orcids":["https://orcid.org/0000-0002-1253-1752"]},"institutions":[{"id":"https://openalex.org/I4210088555","display_name":"Abbott (United States)","ror":"https://ror.org/0052svj16","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gerard B. Fox","raw_affiliation_strings":["Global Pharmaceutical Research and Development, Translational Neuroimaging, Abbott, Abbott Park, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Pharmaceutical Research and Development, Translational Neuroimaging, Abbott, Abbott Park, IL, USA","institution_ids":["https://openalex.org/I4210088555"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210088555"],"apc_list":{"value":2042,"currency":"GBP","value_usd":2693},"apc_paid":null,"fwci":0.3392,"has_fulltext":true,"cited_by_count":5,"citation_normalized_percentile":{"value":0.53221075,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"13","issue":"03","first_page":"291","last_page":"291"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.9375,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.9375,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.017400000244379044,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.00559999980032444,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dopamine-d3-receptor","display_name":"dopamine D3 receptor","score":0.9150000214576721},{"id":"https://openalex.org/keywords/target-engagement","display_name":"target engagement","score":0.7739999890327454},{"id":"https://openalex.org/keywords/11c-phno","display_name":"[11C]-(+)-PHNO","score":0.8550000190734863},{"id":"https://openalex.org/keywords/positron-emission-tomography","display_name":"positron emission tomography","score":0.6499999761581421},{"id":"https://openalex.org/keywords/d3-receptor-antagonists","display_name":"D3 receptor antagonists","score":0.6850000023841858},{"id":"https://openalex.org/keywords/midbrain","display_name":"midbrain","score":0.4790000021457672},{"id":"https://openalex.org/keywords/plasma-exposure","display_name":"plasma exposure","score":0.6000000238418579},{"id":"https://openalex.org/keywords/receptor-occupancy","display_name":"receptor occupancy","score":0.6890000104904175},{"id":"https://openalex.org/keywords/antipsychotic-drugs","display_name":"antipsychotic drugs","score":0.5789999961853027},{"id":"https://openalex.org/keywords/drug-selectivity","display_name":"drug selectivity","score":0.3700000047683716}],"concepts":[{"id":"https://openalex.org/C199596767","wikidata":"https://www.wikidata.org/wiki/Q21110872","display_name":"Dopamine receptor D3","level":4,"score":0.6935508251190186},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.6143361330032349},{"id":"https://openalex.org/C44208683","wikidata":"https://www.wikidata.org/wiki/Q15335165","display_name":"Dopamine receptor D2","level":3,"score":0.593063235282898},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4878382980823517},{"id":"https://openalex.org/C60592354","wikidata":"https://www.wikidata.org/wiki/Q4914018","display_name":"Binding potential","level":3,"score":0.43357953429222107},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.4293833374977112},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.4105471968650818},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.4040508568286896},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.3205080032348633},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3164627254009247},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2980755567550659}],"mesh":[{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000000981","qualifier_name":"diagnostic imaging","is_major_topic":true},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010078","descriptor_name":"Oxazines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D049268","descriptor_name":"Positron-Emission Tomography","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D050637","descriptor_name":"Receptors, Dopamine D3","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D050637","descriptor_name":"Receptors, Dopamine D3","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1017/s1461145710000180","doi":"https://doi.org/10.1017/s1461145710000180","is_oa":true,"landing_page_url":"https://doi.org/10.1017/s1461145710000180","pdf_url":"https://academic.oup.com/ijnp/article-pdf/13/3/291/1865168/13-3-291.pdf","source":{"id":"https://openalex.org/S199972112","display_name":"The International Journal of Neuropsychopharmacology","issn_l":"1461-1457","issn":["1461-1457","1469-5111"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311647","host_organization_name":"University of Oxford","host_organization_lineage":["https://openalex.org/P4310311647"],"host_organization_lineage_names":["University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The International Journal of Neuropsychopharmacology","raw_type":"journal-article"},{"id":"pmid:20196920","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20196920","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The international journal of neuropsychopharmacology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1017/s1461145710000180","doi":"https://doi.org/10.1017/s1461145710000180","is_oa":true,"landing_page_url":"https://doi.org/10.1017/s1461145710000180","pdf_url":"https://academic.oup.com/ijnp/article-pdf/13/3/291/1865168/13-3-291.pdf","source":{"id":"https://openalex.org/S199972112","display_name":"The International Journal of Neuropsychopharmacology","issn_l":"1461-1457","issn":["1461-1457","1469-5111"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311647","host_organization_name":"University of Oxford","host_organization_lineage":["https://openalex.org/P4310311647"],"host_organization_lineage_names":["University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The International Journal of Neuropsychopharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2150128170.pdf","grobid_xml":"https://content.openalex.org/works/W2150128170.grobid-xml"},"referenced_works_count":12,"referenced_works":["https://openalex.org/W1967139897","https://openalex.org/W1969866636","https://openalex.org/W1978301891","https://openalex.org/W1984596181","https://openalex.org/W2024973096","https://openalex.org/W2048458184","https://openalex.org/W2050540523","https://openalex.org/W2154711995","https://openalex.org/W2155177235","https://openalex.org/W2304131176","https://openalex.org/W2308013795","https://openalex.org/W4250218096"],"related_works":["https://openalex.org/W2154711995","https://openalex.org/W2050540523","https://openalex.org/W1967139897","https://openalex.org/W2014566124","https://openalex.org/W2080386276","https://openalex.org/W2751146379","https://openalex.org/W1965411329","https://openalex.org/W2113971120","https://openalex.org/W2625012370","https://openalex.org/W2090592015"],"abstract_inverted_index":{"Dopamine":[0],"D3":[1,58,460,677],"receptors":[2,59,461,680],"(D3Rs)":[3],"may":[4],"afford":[5],"the":[6,28,45,53,61,76,96,117,164,200,205,213,232,251,335,342,395,439,513,534,566,573,589,598,611,623,630,648,668,671,695,722,758,770,784,790,844,870,880],"ability":[7],"to":[8,26,94,124,185,189,209,255,291,467,520,539,544,636,700,789,836],"treat":[9],"a":[10,48,92,144,161,180,370,426,465,480,485,525,799,857],"wide":[11],"variety":[12],"of":[13,31,47,55,78,98,101,126,207,235,246,253,294,321,337,398,438,441,454,493,516,530,537,632,670,708,801,814,838,846,893],"neuropsychiatric":[14],"disorders":[15],"(Graff-Guerrero":[16,104,345,374,736],"et":[17,105,108,111,166,346,375,378,448,473,476,507,577,580,583,586,627,703,737,742,745,822],"al.2009b).":[18],"Until":[19],"recently,":[20],"there":[21,277,282,433,617,855],"was":[22,42,394,524,546,558,570,681],"no":[23,134,435],"non-invasive":[24],"way":[25],"determine":[27,95,256,540],"physical":[29],"interaction":[30],"antagonists":[32,103],"with":[33,141,202,222,287,313,391,484,765,798,851],"D3Rs":[34,127,187,194,247,637,701,806,820,839],"in":[35,60,64,128,152,195,211,237,267,304,324,341,354,417,446,470,488,496,502,572,638,657,694,757,769,783,840,865,884],"animals":[36],"and":[37,52,57,146,219,248,350,360,459,499,597,608,664,678,688,729,752,762,772,786,793,825,859],"humans.":[38,153,866],"In":[39,170,643,809],"part,":[40],"this":[41,249],"driven":[43,551],"by":[44,552,803,811],"absence":[46,845],"D3R-selective":[49,881],"PET":[50,302,563],"tracer":[51],"co-localization":[54],"D2":[56,458,679],"CNS.":[62,842],"Further,":[63,348],"most":[65,238,268,723],"brain":[66,239,285],"regions,":[67],"D2R":[68,135,150,270,416,590,663,847,863],"density":[69,234,271],"is":[70,177,241,264,272,278,381,424,434,697,856],"higher":[71,243],"than":[72,244,274],"D3R":[73,85,102,118,217,223,257,275,289,295,364,388,414,481,599,649,665,718,727,873],"density.":[74],"Recently,":[75,154],"identification":[77],"midbrain":[79,359,696],"regions":[80,240,286,329,362,368,384,498,505,620,640,720,732,813],"that":[81,116,175,199,231,245,266,281,309,357,385,407,422,432,512,522,555,616,674,692,816,831,854,872],"are":[82,283,796,817,891],"selective":[83,181,594,604,653,719],"for":[84,193,260,413,676,726,781,819,879],"have":[86,114,159,352,462,828],"been":[87,711],"revealed":[88],"using":[89,297,306,685,749,886],"[11C](+)-PHNO,":[90,442],"affording":[91],"method":[93],"level":[97],"target":[99,389,541,874],"engagement":[100,390,542,875],"al.2009b;":[106,376],"Rabiner":[107,155,226,349,377,402,447,475,582,744,751],"al.2009).":[109,379,477,704,746],"Graff-Guerrero":[110,165,824],"al.":[112,167,449],"(2009b)":[113,168,827],"demonstrated":[115,308,353,463,556,610,712,830],"antagonist,":[119,882],"ABT-925,":[120,142,392,883],"can":[121,833,876],"block":[122],"up":[123,835],"74%":[125,837],"humans":[129,885],"at":[130,457,805],"doses":[131],"tested.":[132],"Moreover,":[133,299,843],"antagonist-associated":[136,848],"adverse":[137,849],"events":[138,850],"were":[139,518,550,618,641],"observed":[140,571,754],"indicating":[143],"significant":[145,858],"meaningful":[147,860],"separation":[148,861],"from":[149,560,862],"occupancy":[151,258,296,323,725,780,864],"&":[156,227,403],"Laruelle":[157,228,404,607],"(2010)":[158,229,405],"provided":[160],"commentary":[162,172],"on":[163],"paper.":[169],"their":[171],"they":[173],"assert":[174],"ABT-925":[176,203,782,804,832,852],"unsuitable":[178],"as":[179,331,443,565,622,660,662],"antagonist":[182,591,650],"alongside":[183],"[11C](+)-PHNO":[184,208,254,307,340,408,423,455,523,538,557,633,672,802],"image":[186],"due":[188],"its":[190],"limited":[191],"selectivity":[192,412,440,469,487],"vivo.":[196,418],"We":[197],"maintain":[198],"experiment":[201],"demonstrates":[204,853],"usefulness":[206],"examine":[210],"vivo":[212],"relationship":[214],"between":[215,464],"human":[216,284,301,841],"binding":[218,495,569,634,693,756,768],"plasma":[220],"exposures":[221],"antagonists.":[224],"First,":[225],"note":[230,406,431],"relative":[233],"D2Rs":[236,325],"significantly":[242],"affects":[250],"utility":[252,536],"status":[259],"ABT-925.":[261],"While":[262],"it":[263],"true":[265,535],"areas":[269],"greater":[273],"density,":[276],"compelling":[279],"evidence":[280,615],"sufficient":[288,519],"exclusivity":[290],"allow":[292],"determination":[293,437],"[11C](+)-PHNO.":[298,887],"recent":[300],"studies":[303,453,554],"schizophrenia":[305],"chronic":[310],"antipsychotic":[311],"treatment":[312],"olanzapine,":[314],"clozapine":[315],"or":[316],"risperidone,":[317],"produced":[318],"high":[319],"levels":[320],"receptor":[322,514,724,767,779],"but":[326],"not":[327,425],"D3R-rich":[328,497],"such":[330,621],"globus":[332,343,574,624,763,794],"pallidus,":[333],"while":[334],"addition":[336],"pramipexole":[338],"displaced":[339],"pallidus":[344,575,625,764,795],"al.2009a).":[347],"colleagues":[351,609,753,826],"non-human":[355,658],"primates":[356,659],"some":[358],"forebrain":[361],"express":[363],"exclusively,":[365],"whilst":[366],"other":[367,561],"exhibit":[369],"mixed":[371,503,730],"D2R/D3R":[372,504,562,731],"population":[373],"It":[380],"those":[382],"D3-selective":[383,427],"unequivocally":[386],"demonstrate":[387,521,691],"which":[393],"over-riding":[396],"goal":[397],"our":[399,531],"study.":[400],"Second,":[401],"has":[409,710],"only":[410],"\u223c20-fold":[411],"over":[415,595,605,654],"Whilst":[419],"we":[420,429],"agree":[421],"tracer,":[428],"respectfully":[430],"precise":[436],"recently":[444],"noted":[445],"(2009).":[450],"Indeed,":[451],"previous":[452],"affinity":[456],"30-":[466],"50-fold":[468],"vitro":[471],"(Freedman":[472],"al.1994;":[474],"Accordingly,":[478],"BP-897,":[479],"partial":[482,600],"agonist":[483,601],"70-fold":[486],"vitro,":[489],"produces":[490],"57%":[491],"blockade":[492,501,800],"PHNO":[494],"29%":[500],"(Narendran":[506,626],"al.2006).":[508,628],"The":[509,528,774],"authors":[510,890],"concluded":[511],"occupancies":[515,735],"BP-897":[517],"D3R-preferring":[526,619],"agonist.":[527],"evolution":[529],"understanding":[532],"regarding":[533],"prior":[543],"2009":[545],"challenging.":[547],"However,":[548,629],"advances":[549],"several":[553],"unique":[559],"ligands,":[564],"highest":[567],"regional":[568],"(Ginovart":[576],"al.2006;":[578,743],"Narendran":[579,741],"al.2009;":[581,584],"Willeit":[585],"al.2008).":[587],"Using":[588],"SV-156":[592],"(20-fold":[593],"D3)":[596],"BP-187":[602],"(70-fold":[603],"D2),":[606],"first":[612],"in-vivo":[613,689],"pharmacological":[614],"fractions":[631],"attributable":[635,699],"these":[639,715],"unknown.":[642],"an":[644],"elegant":[645],"study":[646],"employing":[647],"SB277011":[651],"(100-fold":[652],"D2in":[655],"vitro),":[656],"well":[661],"knockout":[666],"mice,":[667],"fraction":[669],"signal":[673],"accounted":[675],"determined.":[682],"Those":[683],"data,":[684],"quantitative":[686],"autoradiography":[687],"PET,":[690],"entirely":[698],"(Rabiner":[702,821],"A":[705],"consistent":[706,797],"pattern":[707],"effects":[709],"across":[713],"all":[714],"validation":[716],"studies;":[717],"show":[721,733],"antagonists,":[728],"lower":[734],"al.2008,":[738],"2009a,":[739],"b;":[740],"For":[747],"example,":[748],"SB-277011":[750],"greatest":[755],"substantial":[759],"nigra,":[760],"thalamus":[761],"low":[766],"caudate":[771,785],"putamen.":[773],"significant,":[775],"although":[776],"numerically":[777],"smaller,":[778],"putamen":[787],"compared":[788],"substantia":[791],"nigra":[792],"vs.":[807],"D2Rs.":[808],"conclusion,":[810],"utilizing":[812],"interest":[815],"enriched":[818],"al.2009),":[823],"successfully":[829],"occupy":[834],"Such":[867],"data":[868],"support":[869],"conclusion":[871],"be":[877],"assessed":[878],"None.":[888],"All":[889],"employees":[892],"Abbott":[894],"Laboratories.":[895]},"counts_by_year":[{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}